or Try an Advanced Search...

    Solid Tumors Stocks List

    Symbol Grade Name % Change
    XOMA C XOMA Corporation 0.12
    XLO D Xilio Therapeutics, Inc. 6.48
    VINC F Vincera Pharma, Inc. -3.48
    TSBX F Turnstone Biologics Corp. -3.66
    THAR F Tharimmune, Inc. 0.38
    TCRX C TScan Therapeutics, Inc. 1.12
    TCBP F TC BioPharm (Holdings) plc -1.32
    STTK D Shattuck Labs, Inc. 2.23
    SNTI D Senti Biosciences, Inc. -1.08
    SNDX D Syndax Pharmaceuticals, Inc. -2.77
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Devices Other Shell Companies
    Related Stock Lists: Biotechnology Cancer Immune System Cancer Immunotherapy Life Sciences Medicine Clinical Medicine Immunology Immunotherapy Acute Myeloid Leukemia Antibodies Antibody Autoimmune Disease Biology Biopharmaceutical Breast Cancer Cell Therapy Inflammatory Lymphoma Treatment Of Cancer

    Related ETFs - A few ETFs which own one or more of the above listed Solid Tumors stocks.

    Symbol Grade Name Weight
    SURI D Simplify Exchange Traded Funds Simplify Propel Opportunities ETF 7.52
    CNCR D Loncar Cancer Immunotherapy ETF 1.27
    SBIO C ALPS Medical Breakthroughs ETF 1.19
    XBI C SPDR S&P Biotech ETF 0.98
    BBC D Virtus LifeSci Biotech Clinical Trials ETF 0.87
    View all Solid Tumors ETFs...
    Compare ETFs
    Compare CNCR to XBI Compare SURI to BBC Compare SURI to SBIO

        Solid Tumors Stocks Recent News

        Date Stock Title
        May 15 SNDX Syndax Pharmaceuticals Appoints Aleksandra Rizo, M.D., Ph.D. to the Board of Directors
        May 15 TCBP TCBP Announces Launch of Compassionate Use Program for TCB008
        May 15 VINC Vincerx Pharma GAAP EPS of -$0.58
        May 14 VINC Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
        May 14 STTK Shattuck Labs to Present Additional Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients at th...
        May 14 TSBX Turnstone Biologics reports Q1 results
        May 14 XLO Xilio Therapeutics GAAP EPS of -$0.62
        May 14 XOMA XOMA to Present at H.C. Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQ
        May 14 XLO Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2024 Financial Results
        May 14 TCRX TScan Therapeutics First Quarter 2024 Earnings: Misses Expectations
        May 13 TSBX Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights
        May 13 TCRX TScan Therapeutics GAAP EPS of -$0.32, revenue of $0.56M
        May 13 TCRX TScan Therapeutics, Inc. (TCRX) Reports Q1 Loss, Lags Revenue Estimates
        May 13 SNTI Senti Bio Announces First Patient Dosed in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia
        May 13 TCRX Key Takeaways From TScan Therapeutics Analyst Ratings
        May 13 TCRX TScan Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
        May 12 SNDX Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q1 2024 Earnings Call Transcript
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Devices Other Shell Companies
        Related Stock Lists: Biotechnology Cancer Immune System Cancer Immunotherapy Life Sciences Medicine Clinical Medicine Immunology Immunotherapy Acute Myeloid Leukemia Antibodies Antibody Autoimmune Disease Biology Biopharmaceutical Breast Cancer Cell Therapy Inflammatory Lymphoma Treatment Of Cancer
        Solid Tumors

        Solid tumors are masses of abnormal cells that form when cells in the body divide and grow uncontrollably. They are usually found in the organs, but can also form in the tissues of the body. Solid tumors can be benign (non-cancerous) or malignant (cancerous).

        Browse All Tags